In summary, we identified two pathogenic variants, one likely pathogenic variant and one SNP in the TMC1 gene by HTS in four Chinese hearing loss families, including the second report of the p.M412K variant orthologous to that in Bth mice, which are a good model for gene therapy analysis. This evidence concerns the gene TMC1 and hearing loss disorder.